Near real-time vaccine safety surveillance with partially accrued data

Pharmacoepidemiology and Drug Safety

Volumn 20, Issue 6, 2011, Pages 583-590

  Greene, Sharon K ^c   Kulldorff, Martin ^c   Yin, Ruihua ^c   Yih, W Katherine ^c   Lieu, Tracy A ^c   Weintraub, Eric S ^a   Lee, Grace M ^b,c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Influenza vaccine; Near real time surveillance; Quality control; Vaccine safety

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; SEASONAL INFLUENZA; SEQUENTIAL ANALYSIS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; BIAS (EPIDEMIOLOGY); HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; POISSON DISTRIBUTION; PRODUCT SURVEILLANCE, POSTMARKETING; RISK; TIME FACTORS;

EID: 79959558526     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2133     Document Type: Article

References (19)

1. Lieu TA, Kulldorff M, Davis RL, et al. Real-time vaccine safety surveillance for the early detection of adverse events. Med Care 2007; 45: S89-S95. doi: 10.1097/MLR.0b013e3180616c0a
2. Zhou W, Pool V, Iskander JK, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001. MMWR Surveill Summ 2003; 52: 1-24.
3. Centers for Disease Control and Prevention (CDC). Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine. MMWR Morb Mortal Wkly Rep 2008; 57: 258-260. doi: mm5710a3
4. Yih WK, Nordin JD, Kulldorff M, et al. An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink. Vaccine 2009; 27: 4257-4262. doi: 10.1016/j.vaccine.2009.05.036
5. Belongia EA, Irving SA, Shui IM, et al. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J 2010; 29: 1-5. doi: 10.1097/INF.0b013e3181af8605
6. US Department of Health and Human Services. Vaccine monitoring and data collection. S6-III.B3. HHS Pandemic Influenza Plan. Supplement 6, Vaccine Distribution and Use. US Department of Health & Human Services: Washington, DC, 2005. [9 March 2010].
7. Centers for Disease Control and Prevention (CDC). Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009; 58: 1-8. doi: rr5810a1
8. Lee GM, Greene SK, Baggs J, et al. Safety of H1N1 and seasonal influenza vaccines in the Vaccine Safety Datalink. Pediatric Academic Societies Annual Meeting, Vancouver, Canada, 1-4 May 2010.
9. Chen RT, DeStefano F, Davis RL, et al. The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. Bull World Health Organ 2000; 78: 186-194.
10. DeStefano F. The Vaccine Safety Datalink project. Pharmacoepidemiol Drug Saf 2001; 10: 403-406.
11. Greene SK, Kulldorff M, Lewis EM, et al. Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink project. Am J Epidemiol 2010; 171: 177-188. doi: 10.1093/aje/kwp345
12. Kulldorff M, Davis RL, Kolczak M, Lewis E, Lieu T, Platt R. A maximized sequential probability ratio test for drug and vaccine safety surveillance. Sequential Anal 2011; 30: 58-78.
13. Li L, Kulldorff M. A conditional maximized sequential probability ratio test for pharmacovigilance. Stat Med 2010; 29: 284-295. doi: 10.1002/sim.3780
14. Louis TA, Lavori PW, Bailar JC, 3rd, Polansky M. Crossover and self-controlled designs in clinical research. N Engl J Med Jan 5 1984; 310(1): 24-31.
15. Izurieta H. Safety monitoring of 2009 pandemic H1N1 influenza vaccines. Vaccines and Related Biological Products Advisory Committee Meeting, Bethesda, MD, 18 November 2009. [5 March 2010].
16. Greene SK, Shi P, Dutta-Linn MM, et al. Accuracy of data on influenza vaccination status at four Vaccine Safety Datalink sites. Am J Prev Med 2009; 37: 552-555. doi: 10.1016/j.amepre.2009.08.022
17. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol 1979; 110: 105-123.
18. Brown JS, Moore KM, Braun MM, et al. Active influenza vaccine safety surveillance: potential within a healthcare claims environment. Med Care 2009; 47: 1251-1257. doi: 10.1097/MLR.0b013e3181b58b5c
19. Raymond B. The Kaiser Permanente IT transformation. Healthc Financ Manage 2005; 59: 62-66.